These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11692359)

  • 1. MRI earns praise in prostate screening of high-risk patients.
    Krotz D
    Diagn Imaging (San Franc); 1999 Jan; Suppl():IR21-3. PubMed ID: 11692359
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer.
    Hara N; Okuizumi M; Koike H; Kawaguchi M; Bilim V
    Prostate; 2005 Feb; 62(2):140-7. PubMed ID: 15389803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
    Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
    Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve?
    Latchamsetty KC; Borden LS; Porter CR; Lacrampe M; Vaughan M; Lin E; Conti N; Wright JL; Corman JM
    Can J Urol; 2007 Feb; 14(1):3429-34. PubMed ID: 17324322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.
    Lawrentschuk N; Fleshner N
    BJU Int; 2009 Mar; 103(6):730-3. PubMed ID: 19154475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does body-coil magnetic-resonance imaging have a role in the preoperative staging of patients with clinically localized prostate cancer?
    Allen DJ; Hindley R; Clovis S; O'Donnell P; Cahill D; Rottenberg G; Popert R
    BJU Int; 2004 Sep; 94(4):534-8. PubMed ID: 15329107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phased array magnetic resonance imaging for staging clinically localised prostrate cancer.
    Borre M; Lundorf E; Marcussen N; Langkilde NC; Wolf H
    Acta Oncol; 2005; 44(6):589-92. PubMed ID: 16294442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of phased-array 3.0-T and endorectal 1.5-T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer.
    Park BK; Kim B; Kim CK; Lee HM; Kwon GY
    J Comput Assist Tomogr; 2007; 31(4):534-8. PubMed ID: 17882027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostatic carcinoma: current status of diagnostic imaging].
    Bloch BN; Helbich T; Heinz-Peer G
    Wien Med Wochenschr Suppl; 2002; (113):89-91. PubMed ID: 12621851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging.
    Macura KJ
    Semin Roentgenol; 2008 Oct; 43(4):303-13. PubMed ID: 18774034
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current role of MRI for the local staging of prostate cancer].
    Busquets JC; Batlle JC; Obregón JB; Ortega MV; Morell NR
    Arch Esp Urol; 2006 Dec; 59(10):1001-10. PubMed ID: 17283713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancements in magnetic resonance imaging of the prostate.
    Macura KJ
    Top Magn Reson Imaging; 2008 Dec; 19(6):259-60. PubMed ID: 19512847
    [No Abstract]   [Full Text] [Related]  

  • 14. [1H magnetic resonance spectroscopy of the prostate].
    Mueller-Lisse UG; Scherr M
    Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance.
    Villers A; Lemaitre L; Haffner J; Puech P
    Curr Opin Urol; 2009 May; 19(3):274-82. PubMed ID: 19325494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How good is MRI at detecting and characterising cancer within the prostate?
    Kirkham AP; Emberton M; Allen C
    Eur Urol; 2006 Dec; 50(6):1163-74; discussion 1175. PubMed ID: 16842903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
    Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
    Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MR imaging of prostate cancer].
    Heuck A; Scheidler J; Sommer B; Graser A; Müller-Lisse UG; Massmann J
    Radiologe; 2003 Jun; 43(6):464-73. PubMed ID: 12827261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of imaging in the diagnosis and staging of prostatic adenocarcinomas].
    Cornud F; Oyen R
    J Radiol; 2002 Jun; 83(6 Pt 2):863-80, discussion 881-2. PubMed ID: 12218860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
    J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.